A Study to Investigate Cabotegravir for Neonates Exposed to HIV-1
NCT07275606
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
66
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Oral CAB
DRUG:
IM CAB LA
Sponsor
ViiV Healthcare